Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy Janet SultanaFrancesco TrottaGianluca Trifirò Meeting Report 22 October 2019 Pages: 1 - 5
Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous Reports Esmé J. BaanVeronique A. de SmetKatia M. C. Verhamme Original Research Article Open access 15 October 2019 Pages: 7 - 16
Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) Taylor M. PatekChengwen TengChristopher R. Frei Original Research Article 18 October 2019 Pages: 17 - 22
Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis Neil M. SchultzDavid F. PensonBenjamin Lowentritt Original Research Article 05 October 2019 Pages: 23 - 33
Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures Lennart NathellAnnegret GohlkeStefan Wohlfeil Original Research Article Open access 03 October 2019 Pages: 35 - 43
Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union Christina E. HoeveReynold D. C. FranciscaSabine M. J. M. Straus Original Research Article Open access 16 October 2019 Pages: 45 - 55
Application of Augmented Intelligence for Pharmacovigilance Case Seriousness Determination Ramani RoutrayNiki TetarenkoEdward Mingle Original Research Article Open access 11 October 2019 Pages: 57 - 66
Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance Justin MowerTrevor CohenDevika Subramanian Original Research Article 23 October 2019 Pages: 67 - 77